• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number 0500316E
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/19/2022
Event Type  malfunction  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
A materials manager reported that a dialyzer blood leak occurred during a hemodialysis (hd) treatment.In a follow up with the hemodialysis (hd) technician it was clarified that the blood leak occurred 30 minutes into the hd treatment.The blood leak was described as being an external blood leak that was visually seen as blood was dripping from an area where the hansen meets the cylinder of the dialyzer.Blood tests strips were used and tested positive for the presence of blood.The machine was a fresenius 2008k2 machine.The machine did not alarm.There was no damage noted on the dialyzer.The patient¿s estimated blood loss (ebl) was 250 ml.There was no patient injury, adverse events, or medical intervention required as a result of this event.The patient was able to complete treatment on a different machine with new supplies.The device is available to be returned to the manufacturer for evaluation.
 
Event Description
A materials manager reported that a dialyzer blood leak occurred during a hemodialysis (hd) treatment.In a follow up with the hemodialysis (hd) technician it was clarified that the blood leak occurred within the first 30 minutes of hd treatment.The blood leak was described as being an external blood leak that was visually seen as blood was dripping from an area where the hansen meets the cylinder of the dialyzer.Blood tests strips were used and tested positive for the presence of blood.The machine was a fresenius 2008k2 machine.The machine did not alarm.There was no damage noted on the dialyzer.The patient¿s estimated blood loss (ebl) was 250 ml.There was no patient injury, adverse events, or medical intervention required as a result of this event.The patient was able to complete treatment on a different machine with new supplies.The device is available to be returned to the manufacturer for evaluation.
 
Manufacturer Narrative
Additional information: d.9.,g.1.,h.3.Product investigation: a sample has not been provided for evaluation.The third party carrier's website was reviewed and it was verified that the shipping materials were sent to the customer and were subsequently received.In the event a sample is returned for evaluation, the complaint file will be updated.The report could not be confirmed as a definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint sample.A review of the production record was performed.The production record review showed there was one approved temporary deviation notice in the production of this lot.It is unrelated to the reported complaint event.There was no indication of product non-acceptance or deviation in the manufacturing process related to the complaint event.This includes non-conformances, rework, labeling, process controls, and any other occurrence in production that was potentially related to the complaint.The reported lot number passed pyrogen testing, was within sterilization dosage parameters and passed all release criteria.There is no recall associated with this complaint.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program in order to assess and improve our products and processes.Capas for vision systems and blood leak reduction are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 160NRE DIALYZER FINISHED ASSY.
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer (Section G)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key14210655
MDR Text Key290097230
Report Number0001713747-2022-00141
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100149
UDI-Public00840861100149
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K162488
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 06/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number0500316E
Device Catalogue Number0500316E
Device Lot Number21NU06011
Was Device Available for Evaluation? No
Device AgeMO
Date Manufacturer Received05/27/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/12/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FRESENIUS 2008K2; FRESENIUS 2008K2
Patient SexFemale
-
-